Phase I study of docetaxel plus ifosfamide in patients with advanced cancer


Autoria(s): Marx, G.; Lewis, C.; Hall, K.; Levi, J.; Ackland, S.
Data(s)

01/01/2002

Identificador

http://hdl.handle.net/10536/DRO/DU:30052321

Idioma(s)

eng

Publicador

Nature Publishing Group

Relação

http://dro.deakin.edu.au/eserv/DU:30052321/hall-phase1study-2002.pdf

http://dx.doi.org/10.1038/sj.bjc.6600542

Palavras-Chave #ifosfamide #docetaxel #malignancy #toxicity #G-CSF
Tipo

Journal Article